RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral

Bibliographic Details
Main Authors:	Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, David S. Perlin, Sivanesan Dakshanamurthy
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.1098

Internet

https://doi.org/10.1002/ctm2.1098